Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 10.8% in the afternoon session after RBC analyst Brian ...

What makes this new study different is the duration and depth of analysis. The liver was fully vascularized and remained ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...

The frustrating part is that you can't predict how long it will take' says Frenchman, who has yet to race in 2025 ...

A young man treated with Elevidys died of acute liver failure. The case may give doctors pause before prescribing the ...

StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Sunday. The firm issued a sell rating on the stock. Trinity Biotech Trading Down ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...

Most humans have long-lived infections in various tissues—including in the nervous system—that typically do not result in ...